Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)Enrique Grande, Rocio García‐Carbonero, Jesús García-Donás et al.|Annals of Oncology|2015Cited by 157
Detection of Early-Stage Pancreatic Ductal Adenocarcinoma From Blood Samples: Results of a Multiplex Biomarker Signature Validation StudyRandall E. Brand, Thomas C. King, Jan Persson et al.|Clinical and Translational Gastroenterology|2022Cited by 42
The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk IndividualsGeorge Zogopoulos, Ido Haimi, Shenin A. Sanoba et al.|Journal of the National Comprehensive Cancer Network|2024Cited by 24
Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer SurveillanceBryson W. Katona, Raymond Wadlow, Kelsey Klute et al.|Cancer Prevention Research|2023Cited by 20
The PRECEDE consortium: A longitudinal international cohort study of individuals with genetic risk or familial pancreatic cancer.George Zogopoulos, Diane M. Simeone, Yan Bi et al.|Journal of Clinical Oncology|2022Cited by 2